![John Mekalanos](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
John Mekalanos
Keine laufenden Positionen mehr
Profil
John Mekalanos is a Director of PharmAthene, Inc. He is a Professor and Chairman of the Department of Microbiology and Molecular Genetics at Harvard Medical School.
He was Founder of Virus Research Institute, Inc. and Versicor, Inc. He was the Head of the Biology Scientific Advisory Board of Versicor, Inc. He is a Member of the National Academy of Sciences.
He was a Member of the FDA Advisory Committee on Vaccines and Related Biologics.
He was a Consultant of NIH, the World Health Organization, The International Vaccine Institute.
Ehemalige bekannte Positionen von John Mekalanos
Unternehmen | Position | Ende |
---|---|---|
PharmAthene, Inc. /Old/
![]() PharmAthene, Inc. /Old/ BiotechnologyHealth Technology PharmAthene, Inc. develops biotherapeutics to address biological pathogens and chemicals. It provides clinical and preclinical development for Bacillus anthracis a therapeutic anti-toxin for treatment of symptomatic patients infected with anthrax monoclonal. The company was founded in 2001 and is located in Annapolis, MD. | Gründer | 09.08.2007 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
PharmAthene, Inc. /Old/
![]() PharmAthene, Inc. /Old/ BiotechnologyHealth Technology PharmAthene, Inc. develops biotherapeutics to address biological pathogens and chemicals. It provides clinical and preclinical development for Bacillus anthracis a therapeutic anti-toxin for treatment of symptomatic patients infected with anthrax monoclonal. The company was founded in 2001 and is located in Annapolis, MD. | Health Technology |